Case History: Orkambi® (Ivacaftor/Lumacaftor), for the Treatment of Cystic Fibrosis Patients who are Homozygous for the F508del CFTR Mutation

Autor:	Paul A. Negulescu, Peter D. J. Grootenhuis, Fred Van Goor, Sabine Hadida
Rok vydání:	2018
Předmět:	medicine.medical_specialty business.industry Lumacaftor medicine.disease Gastroenterology Cystic fibrosis Ivacaftor chemistry.chemical_compound chemistry Internal medicine Mutation (genetic algorithm) medicine F508del cftr business medicine.drug
Zdroj:	2018 Medicinal Chemistry Reviews ISBN: 9780996293266 2018 Medicinal Chemistry Reviews
DOI:	10.29200/acsmedchemrev-v53.ch25
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::deee7cefe7ba8d46db26c255719b5c87 https://doi.org/10.29200/acsmedchemrev-v53.ch25 Zobrazit plný text záznamu